Primemd Inc.
PRMD · OTC
12/31/2021 | 3/31/2008 | 3/31/2007 | 3/31/2006 | |
|---|---|---|---|---|
| Revenue | $10,502 | $68 | $49 | $53 |
| % Growth | 15,388.8% | 38% | -6.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $10,502 | $68 | $49 | $53 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6,258 | $172 | $262 | $211 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6,258 | $172 | $262 | $211 |
| Operating Income | $4,159 | -$107 | -$216 | -$165 |
| % Margin | 39.6% | -158.4% | -439.8% | -313.8% |
| Other Income/Exp. Net | -$1,019 | $6 | $411 | $10 |
| Pre-Tax Income | $3,140 | -$101 | $195 | -$156 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | $3,140 | -$101 | $195 | -$156 |
| % Margin | 29.9% | -149.1% | 396.2% | -295.4% |
| EPS | 0.17 | -0.033 | 0.063 | -0.051 |
| % Growth | 616.7% | -151.9% | 225.3% | – |
| EPS Diluted | 0.17 | -0.033 | 0.063 | -0.051 |
| Weighted Avg Shares Out | 18,499 | 3,073 | 3,073 | 3,073 |
| Weighted Avg Shares Out Dil | 18,499 | 3,073 | 3,073 | 3,073 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $20 | $30 | $28 |
| Interest Expense | $202 | $0 | $0 | $0 |
| Depreciation & Amortization | $85 | $4 | $4 | $7 |
| EBITDA | $3,427 | -$104 | -$212 | -$158 |
| % Margin | 32.6% | -153% | -432.3% | -300.1% |